In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $14.62 in the prior trading day, Edgewise Therapeutics Inc (NASDAQ: EWTX) closed at $14.85, up 1.57%. In other words, the price has increased by $1.57 from its previous closing price. On the day, 0.57 million shares were traded. EWTX stock price reached its highest trading level at $15.18 during the session, while it also had its lowest trading level at $14.615.
Ratios:
Our goal is to gain a better understanding of EWTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 28.87 and its Current Ratio is at 28.87. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on July 30, 2025, initiated with a Strong Buy rating and assigned the stock a target price of $46.
On June 30, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $42.
On April 30, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $41.Guggenheim initiated its Buy rating on April 30, 2025, with a $41 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 12 ’25 when MOORE JOHN R sold 2,098 shares for $13.39 per share. The transaction valued at 28,097 led to the insider holds 10,214 shares of the business.
Derakhshan Behrad sold 2,491 shares of EWTX for $33,360 on Aug 12 ’25. The Chief Business Officer now owns 23,645 shares after completing the transaction at $13.39 per share. On Aug 12 ’25, another insider, Carruthers R Michael, who serves as the Chief Financial Officer of the company, sold 1,428 shares for $13.39 each. As a result, the insider received 19,124 and left with 86,162 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EWTX now has a Market Capitalization of 1564388096 and an Enterprise Value of 974762752.
Stock Price History:
The Beta on a monthly basis for EWTX is 0.26, which has changed by -0.2644874 over the last 52 weeks, in comparison to a change of 0.1513431 over the same period for the S&P500. Over the past 52 weeks, EWTX has reached a high of $38.12, while it has fallen to a 52-week low of $10.60. The 50-Day Moving Average of the stock is 7.20%, while the 200-Day Moving Average is calculated to be -30.20%.
Shares Statistics:
The stock has traded on average 773.19K shares per day over the past 3-months and 619760 shares per day over the last 10 days, according to various share statistics. A total of 105.34M shares are outstanding, with a floating share count of 74.56M. Insiders hold about 29.22% of the company’s shares, while institutions hold 84.75% stake in the company. Shares short for EWTX as of 1753920000 were 10192737 with a Short Ratio of 13.18, compared to 1751241600 on 12657398. Therefore, it implies a Short% of Shares Outstanding of 10192737 and a Short% of Float of 11.359999.
Earnings Estimates
Its stock is currently analyzed by 12.0 different market analysts. The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.36 and low estimates of -$0.46.
Analysts are recommending an EPS of between -$1.56 and -$1.67 for the fiscal current year, implying an average EPS of -$1.62. EPS for the following year is -$1.93, with 11.0 analysts recommending between -$1.44 and -$2.35.
